Superpharm Bolton Ltd - Period Ending 2017-07-31
Superpharm Bolton Ltd - Period Ending 2017-07-31
Registration number:
Superpharm Bolton Ltd
for the Year Ended 31 July 2017
1 Pavilion Square
Cricketers Way
Westhoughton
Bolton
BL5 3AJ
Superpharm Bolton Ltd
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Financial Statements |
Superpharm Bolton Ltd
Company Information
Directors |
Mr M Naheem Mr SS Khan Mr KUH Hussain Mr I Khan Mr K Iqbal |
Registered office |
|
Accountants |
|
Page 1 |
Superpharm Bolton Ltd
(Registration number: 09449153)
Balance Sheet as at 31 July 2017
2017 |
2016 |
|
Fixed assets |
|
|
Current assets |
|
|
Creditors: Amounts falling due within one year |
( |
( |
Net current liabilities |
( |
( |
Total assets less current liabilities |
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
Accruals and deferred income |
( |
( |
|
|
|
Capital and reserves |
|
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
For the financial year ending 31 July 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Page 2 |
Superpharm Bolton Ltd
(Registration number: 09449153)
Balance Sheet as at 31 July 2017
Approved and authorised by the
.........................................
Director
.........................................
Director
.........................................
Director
Page 3 |